JP2015518007A5 - - Google Patents

Download PDF

Info

Publication number
JP2015518007A5
JP2015518007A5 JP2015514283A JP2015514283A JP2015518007A5 JP 2015518007 A5 JP2015518007 A5 JP 2015518007A5 JP 2015514283 A JP2015514283 A JP 2015514283A JP 2015514283 A JP2015514283 A JP 2015514283A JP 2015518007 A5 JP2015518007 A5 JP 2015518007A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
schedosporum
schedospodium
prolifenicus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015514283A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015518007A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2013/000487 external-priority patent/WO2013177608A1/en
Publication of JP2015518007A publication Critical patent/JP2015518007A/ja
Publication of JP2015518007A5 publication Critical patent/JP2015518007A5/ja
Pending legal-status Critical Current

Links

JP2015514283A 2012-05-30 2013-05-13 スケドスポリウム属感染症の治療方法 Pending JP2015518007A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2012902243A AU2012902243A0 (en) 2012-05-30 Method of treating Seedosporium spp. infection
AU2012902243 2012-05-30
PCT/AU2013/000487 WO2013177608A1 (en) 2012-05-30 2013-05-13 Method of treating scedosporium spp. infection

Publications (2)

Publication Number Publication Date
JP2015518007A JP2015518007A (ja) 2015-06-25
JP2015518007A5 true JP2015518007A5 (enExample) 2016-06-30

Family

ID=49672167

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015514283A Pending JP2015518007A (ja) 2012-05-30 2013-05-13 スケドスポリウム属感染症の治療方法

Country Status (9)

Country Link
US (1) US9867802B2 (enExample)
EP (1) EP2854799B1 (enExample)
JP (1) JP2015518007A (enExample)
CN (1) CN104519882A (enExample)
AU (2) AU2013204604B2 (enExample)
CA (1) CA2874881A1 (enExample)
SG (1) SG11201407924RA (enExample)
WO (1) WO2013177608A1 (enExample)
ZA (1) ZA201408975B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20200237717A1 (en) * 2017-08-01 2020-07-30 Opal Biosciences Limited Treatment of Staphylococcal and Enterococcal Infections Using Substituted Nitrostyrene Compounds
EP3877371A4 (en) 2018-11-07 2022-07-27 Dana-Farber Cancer Institute, Inc. IMIDAZOPYRIDINE DERIVATIVES AND AZA-IMIDAZOPYRIDINE DERIVATIVES USED AS JANUS KINASE 2 INHIBITORS AND ASSOCIATED USES
US12415816B2 (en) 2018-11-07 2025-09-16 Dana-Farber Cancer Institute, Inc. Benzothiazole derivatives and 7-aza-benzothiazole derivatives as janus kinase 2 inhibitors and uses thereof
EP3876930A4 (en) 2018-11-07 2022-07-20 Dana-Farber Cancer Institute, Inc. BENZIMIDAZOLE DERIVATIVES AND AZA-BENZIMIDAZOLE DERIVATIVES AS JANUS KINASE 2 INHIBITORS AND THEIR USES
WO2021226261A1 (en) 2020-05-06 2021-11-11 Ajax Therapeutics, Inc. 6-heteroaryloxy benzimidazoles and azabenzimidazoles as jak2 inhibitors
EP4267574B1 (en) 2020-12-23 2025-04-23 Ajax Therapeutics, Inc. 6-heteroaryloxy benzimidazoles and azabenzimidazoles as jak2 inhibitors
JP7782035B2 (ja) 2021-11-09 2025-12-08 エイジャックス セラピューティクス, インコーポレイテッド Jak2阻害剤としての6-ヘテロアリールオキシベンゾイミダゾール及びアザベンゾイミダゾール
WO2023086320A1 (en) 2021-11-09 2023-05-19 Ajax Therapeutics, Inc. Forms and compositions of inhibitors of jak2

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3985761A (en) * 1974-10-24 1976-10-12 Sarabhai Research Centre Nitrothiazolyl derivatives of nitrostyrene
JPS585902B2 (ja) * 1978-09-01 1983-02-02 株式会社大塚製薬工場 β↓−ニトロスチレン誘導体
RU2259825C9 (ru) * 2001-06-18 2006-04-10 БиоДием Лимитед Вещества, проявляющие антимикробную, антигрибковую, антипротозойную активности
CA2647374A1 (en) * 2005-10-24 2007-05-03 Staval Pharma, Ltd. Method for treating/controlling/killing fungi and bacteria
US20080220103A1 (en) * 2005-10-24 2008-09-11 Jay Birnbaum Method for treating/controlling/killing fungi and bacteria on living animals
WO2008061308A1 (en) * 2006-11-22 2008-05-29 Biodiem Ltd Protein tyrosine phosphatase modulators
EP2293787A1 (en) * 2008-04-25 2011-03-16 Nanobio Corporation Nanoemulsions for treating fungal, yeast and mold infections
UA107963C2 (xx) * 2010-06-07 2015-03-10 Janssen Pharmaceutica Nv ПРОТИГРИБКОВІ ПОХІДНІ 5,6-ДИГІДРО-4-$(ДИФТОРЕТИЛ)ФЕНІЛ]-4H-ПІРОЛО$1,2-a]$1,4]БЕНЗОДІАЗЕПІНУ І 4-(ДИФТОРЕТИЛ)ФЕНІЛ-6H-ПІРОЛО$1,2-a]$1,4]БЕНЗОДІАЗЕПІНУ

Similar Documents

Publication Publication Date Title
JP2015518007A5 (enExample)
ES2601127T3 (es) Derivado de pirazol y su uso con fines médicos
ES2557303T3 (es) Agente terapéutico para la estenosis del canal espinal
BR112013032122A2 (pt) liberação modificada de 4-metil-3-[[4-(3-piridinil)-2-pirimidinil]amino]-n-[5-(4-metil-1h-imidazol-1-il)-3-(trifluorometil)fenil] benzamida solubilizada usando ácidos orgânicos
JP2013014622A5 (enExample)
HUE043540T2 (hu) Szubsztituált dimer kinazolin-származék, elõállítása, valamint alkalmazása 1-es és 2-es típusú cukorbetegség kezelésére szolgáló gyógyászati készítményekben
JP2012255026A5 (enExample)
JP2010529118A5 (enExample)
JP2017536371A5 (enExample)
JP2015523407A5 (enExample)
JP2016518337A5 (enExample)
JP2015524444A5 (enExample)
HRP20171648T1 (hr) Supstituirani piperidil-etil-pirimidin kao inhibitor grelin-o-acil-transferaze
JP2017515840A5 (enExample)
JP2016540000A5 (enExample)
JP2014062109A5 (enExample)
EA201291104A1 (ru) Пероральные лекарственные формы бендамустина
HRP20180323T1 (hr) Derivat kromona kao antagonist dopaminskog receptora d3 za njegovu upotrebu u liječenju spektra autističnih poremećaja
UY31790A (es) Utilización de dronedarona para preparar un medicamento para el tratamiento de pacientes con arritmia y que tienen un incremento del nivel de creatinina debido a la administración de dronedarona
JP2016538288A5 (enExample)
JP2015516452A5 (enExample)
JP2016540799A5 (enExample)
JP2013541582A5 (enExample)
JP2015536957A5 (enExample)
JP2010526884A5 (enExample)